首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SCHIZOPHRENIA AND/OR TARDIVE DYSKINESIA COMPRISING EICOSAPENTAENOIC ACID AND/OR STEARIDONIC ACID AND PROCESS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA AND/OR TARDIVE DYSKINESIA

PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SCHIZOPHRENIA AND/OR TARDIVE DYSKINESIA COMPRISING EICOSAPENTAENOIC ACID AND/OR STEARIDONIC ACID AND PROCESS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF SCHIZOPHRENIA AND/OR TARDIVE DYSKINESIA

机译：用于治疗精神分裂症和/或迟发性运动障碍的药物组合物，所述精神分裂症和/或迟发性运动障碍包含二十碳五烯酸和/或十八烷酸，以及用于制备治疗精神分裂症和/或迟发性运动障碍的药物的方法

页面导航

摘要
著录项
相似文献

摘要

A pharmaceutical preparation for the treatment of schizophrenia and/or tardive dyskinesia using an oil comprising eicosapentaenoic acid (EPA) and/or stearidonic acid (SA) in amounts of more than 20%, preferably more than 40% and very preferably more than 70% by weight of the total (preferably of the total unsaturated) fatty acids present.

机译：使用包含二十碳五烯酸（EPA）和/或十八碳四烯酸（SA）的量大于20％，优选大于40％，非常优选大于70％的油治疗精神分裂症和/或迟发性运动障碍的药物制剂以全部（优选全部不饱和）脂肪酸的重量计。

著录项

公开/公告号SK44899A3

专利类型
公开/公告日2000-08-14

原文格式PDF
申请/专利权人 SCOTIA HOLDINGS PLC.;
展开▼

申请/专利号SK19990000448
发明设计人 HORROBIN DAVID FREDERIK;
展开▼

申请日1997-10-07
分类号A61K31/20;
国家 SK
入库时间 2022-08-22 01:55:06

相似文献

专利
外文文献
中文文献